ID   PTN12_HUMAN             Reviewed;         780 AA.
AC   Q05209; A4D1C5; B4DKY2; E9PBR5; E9PEH9; Q16130; Q59FD6; Q75MN8;
AC   Q86XU4;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   12-APR-2017, entry version 170.
DE   RecName: Full=Tyrosine-protein phosphatase non-receptor type 12;
DE            EC=3.1.3.48 {ECO:0000269|PubMed:27134172, ECO:0000269|PubMed:8454633};
DE   AltName: Full=PTP-PEST {ECO:0000303|PubMed:8454633};
DE   AltName: Full=Protein-tyrosine phosphatase G1;
DE            Short=PTPG1;
GN   Name=PTPN12;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ILE-322.
RC   TISSUE=Colon;
RX   PubMed=1472029; DOI=10.1016/0006-291X(92)92335-U;
RA   Takekawa M., Itoh F., Hinoda Y., Arimura Y., Toyota M., Sekiya M.,
RA   Adachi M., Imai K., Yachi A.;
RT   "Cloning and characterization of a human cDNA encoding a novel
RT   putative cytoplasmic protein-tyrosine-phosphatase.";
RL   Biochem. Biophys. Res. Commun. 189:1223-1230(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CATALYTIC ACTIVITY.
RX   PubMed=8454633;
RA   Yang Q., Co D., Sommercorn J., Tonks N.K.;
RT   "Cloning and expression of PTP-PEST. A novel, human, nontransmembrane
RT   protein tyrosine phosphatase.";
RL   J. Biol. Chem. 268:6622-6628(1993).
RN   [3]
RP   ERRATUM, AND SEQUENCE REVISION TO 495-517 AND 526-780.
RX   PubMed=8349645;
RA   Yang Q., Co D., Sommercorn J., Tonks N.K.;
RL   J. Biol. Chem. 268:17650-17650(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS ILE-322 AND ALA-573.
RC   TISSUE=Cerebellum, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ILE-322.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 1-8, AND ACETYLATION AT MET-1.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 59-136 (ISOFORM 1), AND VARIANT COLON
RP   CANCER ARG-61.
RX   PubMed=7509295; DOI=10.1016/0014-5793(94)80420-6;
RA   Takekawa M., Itoh F., Hinoda Y., Adachi M., Ariyama T., Inazawa J.,
RA   Imai K., Yachi A.;
RT   "Chromosomal localization of the protein tyrosine phosphatase G1 gene
RT   and characterization of the aberrant transcripts in human colon cancer
RT   cells.";
RL   FEBS Lett. 339:222-228(1994).
RN   [11]
RP   INTERACTION WITH PSTPIP1.
RX   PubMed=9857189; DOI=10.1093/emboj/17.24.7320;
RA   Li J., Nishizawa K., An W., Hussey R.E., Lialios F.E., Salgia R.,
RA   Sunder-Plassmann R., Reinherz E.L.;
RT   "A cdc15-like adaptor protein (CD2BP1) interacts with the CD2
RT   cytoplasmic domain and regulates CD2-triggered adhesion.";
RL   EMBO J. 17:7320-7336(1998).
RN   [12]
RP   PHOSPHORYLATION BY STK24.
RX   PubMed=17046825; DOI=10.1074/jbc.M605035200;
RA   Lu T.J., Lai W.Y., Huang C.Y., Hsieh W.J., Yu J.S., Hsieh Y.J.,
RA   Chang W.T., Leu T.H., Chang W.C., Chuang W.J., Tang M.J., Chen T.Y.,
RA   Lu T.L., Lai M.D.;
RT   "Inhibition of cell migration by autophosphorylated mammalian sterile
RT   20-like kinase 3 (MST3) involves paxillin and protein-tyrosine
RT   phosphatase-PEST.";
RL   J. Biol. Chem. 281:38405-38417(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-673, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [14]
RP   INTERACTION WITH PTK2B/PYK2, AND FUNCTION.
RX   PubMed=17329398; DOI=10.1152/ajpcell.00503.2006;
RA   Sahu S.N., Nunez S., Bai G., Gupta A.;
RT   "Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer
RT   cells.";
RL   Am. J. Physiol. 292:C2288-C2296(2007).
RN   [15]
RP   INTERACTION WITH SORBS2, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=18559503; DOI=10.1158/0008-5472.CAN-08-0958;
RA   Taieb D., Roignot J., Andre F., Garcia S., Masson B., Pierres A.,
RA   Iovanna J.L., Soubeyran P.;
RT   "ArgBP2-dependent signaling regulates pancreatic cell migration,
RT   adhesion, and tumorigenicity.";
RL   Cancer Res. 68:4588-4596(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-689 AND THR-693, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-603 AND SER-673, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332; SER-468; THR-519;
RP   SER-567; THR-569; SER-571; SER-603; SER-606; SER-608; SER-613; SER-689
RP   AND THR-693, VARIANT [LARGE SCALE ANALYSIS] ILE-322, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-435; SER-449 AND
RP   SER-673, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332; SER-435; SER-449;
RP   SER-603; SER-606 AND SER-673, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-332; SER-435;
RP   SER-449; THR-509; SER-571; SER-606 AND SER-673, VARIANT [LARGE SCALE
RP   ANALYSIS] ILE-322, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332; SER-606 AND
RP   SER-673, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [26] {ECO:0000244|PDB:5J8R}
RP   X-RAY CRYSTALLOGRAPHY (2.04 ANGSTROMS) OF 1-305, FUNCTION, CATALYTIC
RP   ACTIVITY, MUTAGENESIS OF SER-19; ARG-36; ARG-63; TYR-64; ASP-66;
RP   ASP-199; HIS-200; ARG-270 AND GLN-278, AND PHOSPHORYLATION AT SER-19.
RX   PubMed=27134172; DOI=10.1016/j.celrep.2016.04.016;
RA   Li H., Yang F., Liu C., Xiao P., Xu Y., Liang Z., Liu C., Wang H.,
RA   Wang W., Zheng W., Zhang W., Ma X., He D., Song X., Cui F., Xu Z.,
RA   Yi F., Sun J.P., Yu X.;
RT   "Crystal structure and substrate specificity of PTPN12.";
RL   Cell Rep. 15:1345-1358(2016).
CC   -!- FUNCTION: Dephosphorylates a range of proteins, and thereby
CC       regulates cellular signaling cascades (PubMed:18559503).
CC       Dephosphorylates cellular tyrosine kinases, such as ERBB2 and
CC       PTK2B/PYK2, and thereby regulates signaling via ERBB2 and
CC       PTK2B/PYK2 (PubMed:17329398, PubMed:27134172). Selectively
CC       dephosphorylates ERBB2 phosphorylated at 'Tyr-1112', 'Tyr-1196',
CC       and/or 'Tyr-1248' (PubMed:27134172). {ECO:0000269|PubMed:17329398,
CC       ECO:0000269|PubMed:18559503, ECO:0000269|PubMed:27134172}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044,
CC       ECO:0000269|PubMed:27134172, ECO:0000269|PubMed:8454633}.
CC   -!- SUBUNIT: Interacts with TGFB1I1 (By similarity). Interacts with
CC       PSTPIP1 (PubMed:9857189). Interacts with PTK2B/PYK2
CC       (PubMed:17329398). Interacts with LPXN (By similarity). Interacts
CC       with SORBS2; this interaction greatly enhances WASF1
CC       dephosphorylation and might mediate partial translocation to focal
CC       adhesion sites (PubMed:18559503). {ECO:0000250|UniProtKB:P35831,
CC       ECO:0000269|PubMed:17329398, ECO:0000269|PubMed:18559503,
CC       ECO:0000269|PubMed:9857189}.
CC   -!- INTERACTION:
CC       P56945:BCAR1; NbExp=4; IntAct=EBI-2266035, EBI-702093;
CC       P00533:EGFR; NbExp=3; IntAct=EBI-2266035, EBI-297353;
CC       P04626:ERBB2; NbExp=4; IntAct=EBI-2266035, EBI-641062;
CC       P09619:PDGFRB; NbExp=3; IntAct=EBI-2266035, EBI-641237;
CC       O43586:PSTPIP1; NbExp=4; IntAct=EBI-2266035, EBI-1050964;
CC       P29353:SHC1; NbExp=4; IntAct=EBI-2266035, EBI-78835;
CC       Q02763:TEK; NbExp=2; IntAct=EBI-2266035, EBI-2257090;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P35831}.
CC       Cell junction, focal adhesion {ECO:0000269|PubMed:18559503}. Cell
CC       projection, podosome {ECO:0000250|UniProtKB:P35831}. Note=Partial
CC       translocation to focal adhesion sites may be mediated by
CC       interaction with SORBS2. {ECO:0000269|PubMed:18559503}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q05209-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q05209-2; Sequence=VSP_046274;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q05209-3; Sequence=VSP_054168;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC   -!- PTM: Phosphorylated by STK24/MST3 and this results in inhibition
CC       of its activity. {ECO:0000269|PubMed:17046825}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Non-receptor class 4 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92761.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D13380; BAA02648.1; -; mRNA.
DR   EMBL; M93425; AAA36529.1; -; mRNA.
DR   EMBL; AK289573; BAF82262.1; -; mRNA.
DR   EMBL; AK296764; BAG59344.1; -; mRNA.
DR   EMBL; AB209524; BAD92761.1; ALT_INIT; mRNA.
DR   EMBL; AC006451; AAQ96881.1; -; Genomic_DNA.
DR   EMBL; CH236949; EAL24198.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW77036.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW77037.1; -; Genomic_DNA.
DR   EMBL; BC050008; AAH50008.2; -; mRNA.
DR   EMBL; S69184; AAB30047.2; -; mRNA.
DR   CCDS; CCDS47619.1; -. [Q05209-3]
DR   CCDS; CCDS47620.1; -. [Q05209-2]
DR   CCDS; CCDS5592.1; -. [Q05209-1]
DR   PIR; JC1368; JC1368.
DR   RefSeq; NP_001124480.1; NM_001131008.1. [Q05209-3]
DR   RefSeq; NP_001124481.1; NM_001131009.1. [Q05209-2]
DR   RefSeq; NP_002826.3; NM_002835.3. [Q05209-1]
DR   UniGene; Hs.61812; -.
DR   PDB; 5HDE; X-ray; 1.62 A; A=1-301.
DR   PDB; 5J8R; X-ray; 2.04 A; A/B/C/D=1-305.
DR   PDBsum; 5HDE; -.
DR   PDBsum; 5J8R; -.
DR   ProteinModelPortal; Q05209; -.
DR   SMR; Q05209; -.
DR   BioGrid; 111746; 48.
DR   IntAct; Q05209; 48.
DR   MINT; MINT-243699; -.
DR   STRING; 9606.ENSP00000248594; -.
DR   BindingDB; Q05209; -.
DR   ChEMBL; CHEMBL3236; -.
DR   DEPOD; Q05209; -.
DR   iPTMnet; Q05209; -.
DR   PhosphoSitePlus; Q05209; -.
DR   BioMuta; PTPN12; -.
DR   DMDM; 317373522; -.
DR   EPD; Q05209; -.
DR   MaxQB; Q05209; -.
DR   PaxDb; Q05209; -.
DR   PeptideAtlas; Q05209; -.
DR   PRIDE; Q05209; -.
DR   DNASU; 5782; -.
DR   Ensembl; ENST00000248594; ENSP00000248594; ENSG00000127947. [Q05209-1]
DR   Ensembl; ENST00000415482; ENSP00000392429; ENSG00000127947. [Q05209-3]
DR   Ensembl; ENST00000435495; ENSP00000397991; ENSG00000127947. [Q05209-2]
DR   GeneID; 5782; -.
DR   KEGG; hsa:5782; -.
DR   UCSC; uc003ugh.3; human. [Q05209-1]
DR   CTD; 5782; -.
DR   DisGeNET; 5782; -.
DR   GeneCards; PTPN12; -.
DR   H-InvDB; HIX0033626; -.
DR   HGNC; HGNC:9645; PTPN12.
DR   HPA; HPA007097; -.
DR   MalaCards; PTPN12; -.
DR   MIM; 600079; gene.
DR   neXtProt; NX_Q05209; -.
DR   OpenTargets; ENSG00000127947; -.
DR   PharmGKB; PA33987; -.
DR   eggNOG; KOG0789; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00870000136380; -.
DR   HOGENOM; HOG000252955; -.
DR   HOVERGEN; HBG007666; -.
DR   InParanoid; Q05209; -.
DR   KO; K18024; -.
DR   OMA; TWSFHGP; -.
DR   OrthoDB; EOG091G0B5O; -.
DR   PhylomeDB; Q05209; -.
DR   TreeFam; TF351977; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   Reactome; R-HSA-1250196; SHC1 events in ERBB2 signaling.
DR   Reactome; R-HSA-182971; EGFR downregulation.
DR   Reactome; R-HSA-186797; Signaling by PDGF.
DR   Reactome; R-HSA-8863795; Downregulation of ERBB2 signaling.
DR   SIGNOR; Q05209; -.
DR   ChiTaRS; PTPN12; human.
DR   GeneWiki; PTPN12; -.
DR   GenomeRNAi; 5782; -.
DR   PRO; PR:Q05209; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000127947; -.
DR   CleanEx; HS_PTPN12; -.
DR   ExpressionAtlas; Q05209; baseline and differential.
DR   Genevisible; Q05209; HS.
DR   GO; GO:0042995; C:cell projection; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; IEA:UniProtKB-SubCell.
DR   GO; GO:0002102; C:podosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0004726; F:non-membrane spanning protein tyrosine phosphatase activity; TAS:ProtInc.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; EXP:Reactome.
DR   GO; GO:0017124; F:SH3 domain binding; IPI:UniProtKB.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; IMP:UniProtKB.
DR   GO; GO:0038128; P:ERBB2 signaling pathway; TAS:Reactome.
DR   GO; GO:1901185; P:negative regulation of ERBB signaling pathway; TAS:Reactome.
DR   GO; GO:2000587; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; TAS:Reactome.
DR   GO; GO:0035335; P:peptidyl-tyrosine dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0042058; P:regulation of epidermal growth factor receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0042246; P:tissue regeneration; IEA:Ensembl.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR012266; Ptpn_12.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PIRSF; PIRSF000932; Tyr-Ptase_nr12; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell junction;
KW   Cell projection; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; Hydrolase;
KW   Phosphoprotein; Polymorphism; Protein phosphatase; Reference proteome.
FT   CHAIN         1    780       Tyrosine-protein phosphatase non-receptor
FT                                type 12.
FT                                /FTId=PRO_0000094771.
FT   DOMAIN       28    293       Tyrosine-protein phosphatase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   REGION       63     67       Substrate binding.
FT                                {ECO:0000305|PubMed:27134172}.
FT   REGION      231    237       Substrate binding. {ECO:0000250}.
FT   REGION      345    438       Interaction with TGFB1I1. {ECO:0000250}.
FT   ACT_SITE    231    231       Phosphocysteine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160,
FT                                ECO:0000255|PROSITE-ProRule:PRU10044}.
FT   BINDING      36     36       Substrate. {ECO:0000305|PubMed:27134172}.
FT   BINDING     199    199       Substrate. {ECO:0000305|PubMed:27134172}.
FT   BINDING     278    278       Substrate. {ECO:0000305|PubMed:27134172}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:12665801}.
FT   MOD_RES      19     19       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:27134172}.
FT   MOD_RES     332    332       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     435    435       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     449    449       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     468    468       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     509    509       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     519    519       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     567    567       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     569    569       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     571    571       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     596    596       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P35831}.
FT   MOD_RES     598    598       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P35831}.
FT   MOD_RES     603    603       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     606    606       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     608    608       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     613    613       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     673    673       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     689    689       Phosphoserine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648}.
FT   MOD_RES     693    693       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:18669648}.
FT   VAR_SEQ       1    130       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046274.
FT   VAR_SEQ       1    119       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_054168.
FT   VARIANT      61     61       K -> R (in colon cancer;
FT                                dbSNP:rs121434623).
FT                                {ECO:0000269|PubMed:7509295}.
FT                                /FTId=VAR_006385.
FT   VARIANT     322    322       V -> I (in dbSNP:rs9640663).
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:1472029,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_019512.
FT   VARIANT     573    573       T -> A (in dbSNP:rs3750050).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_020297.
FT   VARIANT     706    706       E -> K (in dbSNP:rs2230602).
FT                                /FTId=VAR_057129.
FT   MUTAGEN      19     19       S->E: Loss of phosphorylation site.
FT                                {ECO:0000269|PubMed:27134172}.
FT   MUTAGEN      36     36       R->A: Decreases enzyme activity.
FT                                {ECO:0000269|PubMed:27134172}.
FT   MUTAGEN      63     63       R->A: Decreases enzyme activity.
FT                                {ECO:0000269|PubMed:27134172}.
FT   MUTAGEN      64     64       Y->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:27134172}.
FT   MUTAGEN      66     66       D->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:27134172}.
FT   MUTAGEN      67     67       I->A: Nearly abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:27134172}.
FT   MUTAGEN     199    199       D->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:27134172}.
FT   MUTAGEN     200    200       H->A: Decreases enzyme activity.
FT                                {ECO:0000269|PubMed:27134172}.
FT   MUTAGEN     270    270       R->A: Decreases enzyme activity.
FT                                {ECO:0000269|PubMed:27134172}.
FT   MUTAGEN     278    278       Q->A: Nearly abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:27134172}.
FT   CONFLICT    121    121       I -> V (in Ref. 1; BAA02648 and 10;
FT                                AAB30047). {ECO:0000305}.
FT   CONFLICT    612    612       N -> D (in Ref. 4; BAG59344).
FT                                {ECO:0000305}.
FT   HELIX         3     17       {ECO:0000244|PDB:5HDE}.
FT   HELIX        27     42       {ECO:0000244|PDB:5HDE}.
FT   TURN         43     46       {ECO:0000244|PDB:5HDE}.
FT   HELIX        51     54       {ECO:0000244|PDB:5HDE}.
FT   HELIX        56     61       {ECO:0000244|PDB:5HDE}.
FT   HELIX        71     73       {ECO:0000244|PDB:5HDE}.
FT   STRAND       74     76       {ECO:0000244|PDB:5J8R}.
FT   STRAND       90     94       {ECO:0000244|PDB:5HDE}.
FT   STRAND      102    106       {ECO:0000244|PDB:5HDE}.
FT   TURN        111    113       {ECO:0000244|PDB:5HDE}.
FT   HELIX       114    123       {ECO:0000244|PDB:5HDE}.
FT   STRAND      128    131       {ECO:0000244|PDB:5HDE}.
FT   STRAND      135    137       {ECO:0000244|PDB:5HDE}.
FT   STRAND      155    157       {ECO:0000244|PDB:5HDE}.
FT   STRAND      160    170       {ECO:0000244|PDB:5HDE}.
FT   STRAND      173    182       {ECO:0000244|PDB:5HDE}.
FT   STRAND      185    194       {ECO:0000244|PDB:5HDE}.
FT   HELIX       207    219       {ECO:0000244|PDB:5HDE}.
FT   STRAND      222    225       {ECO:0000244|PDB:5HDE}.
FT   STRAND      227    230       {ECO:0000244|PDB:5HDE}.
FT   STRAND      232    235       {ECO:0000244|PDB:5HDE}.
FT   HELIX       236    252       {ECO:0000244|PDB:5HDE}.
FT   HELIX       262    269       {ECO:0000244|PDB:5HDE}.
FT   TURN        270    272       {ECO:0000244|PDB:5HDE}.
FT   HELIX       280    298       {ECO:0000244|PDB:5HDE}.
SQ   SEQUENCE   780 AA;  88106 MW;  663DB3E5176FD7FD CRC64;
     MEQVEILRKF IQRVQAMKSP DHNGEDNFAR DFMRLRRLST KYRTEKIYPT ATGEKEENVK
     KNRYKDILPF DHSRVKLTLK TPSQDSDYIN ANFIKGVYGP KAYVATQGPL ANTVIDFWRM
     IWEYNVVIIV MACREFEMGR KKCERYWPLY GEDPITFAPF KISCEDEQAR TDYFIRTLLL
     EFQNESRRLY QFHYVNWPDH DVPSSFDSIL DMISLMRKYQ EHEDVPICIH CSAGCGRTGA
     ICAIDYTWNL LKAGKIPEEF NVFNLIQEMR TQRHSAVQTK EQYELVHRAI AQLFEKQLQL
     YEIHGAQKIA DGVNEINTEN MVSSIEPEKQ DSPPPKPPRT RSCLVEGDAK EEILQPPEPH
     PVPPILTPSP PSAFPTVTTV WQDNDRYHPK PVLHMVSSEQ HSADLNRNYS KSTELPGKNE
     STIEQIDKKL ERNLSFEIKK VPLQEGPKSF DGNTLLNRGH AIKIKSASPC IADKISKPQE
     LSSDLNVGDT SQNSCVDCSV TQSNKVSVTP PEESQNSDTP PRPDRLPLDE KGHVTWSFHG
     PENAIPIPDL SEGNSSDINY QTRKTVSLTP SPTTQVETPD LVDHDNTSPL FRTPLSFTNP
     LHSDDSDSDE RNSDGAVTQN KTNISTASAT VSAATSTESI STRKVLPMSI ARHNIAGTTH
     SGAEKDVDVS EDSPPPLPER TPESFVLASE HNTPVRSEWS ELQSQERSEQ KKSEGLITSE
     NEKCDHPAGG IHYEMCIECP PTFSDKREQI SENPTEATDI GFGNRCGKPK GPRDPPSEWT
//
